CU20200097A7 - Composición de vacuna contra la hepatitis b, proceso de obtención de dicha composición y sistema de rinovacunación para prevenir y tratar la hepatitis b - Google Patents
Composición de vacuna contra la hepatitis b, proceso de obtención de dicha composición y sistema de rinovacunación para prevenir y tratar la hepatitis bInfo
- Publication number
- CU20200097A7 CU20200097A7 CU2020000097A CU20200097A CU20200097A7 CU 20200097 A7 CU20200097 A7 CU 20200097A7 CU 2020000097 A CU2020000097 A CU 2020000097A CU 20200097 A CU20200097 A CU 20200097A CU 20200097 A7 CU20200097 A7 CU 20200097A7
- Authority
- CU
- Cuba
- Prior art keywords
- composition
- hepatitis
- prevent
- rinovaccination
- obtaining
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 208000006454 hepatitis Diseases 0.000 title 2
- 231100000283 hepatitis Toxicity 0.000 title 2
- 208000002672 hepatitis B Diseases 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 108090001074 Nucleocapsid Proteins Proteins 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 abstract 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
- B05B1/34—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl
- B05B1/3405—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl to produce swirl
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
<p>La presente invención se refiere a una composición de vacuna contra la hepatitis B, caracterizada porque comprende un antígeno de superficie de la hepatitis B y/o un antígeno de nucleocápside de la hepatitis B, y un material a base de gel que comprende polímero de carboxivinilo. La invención se refiere además a un proceso para preparar dicha composición vacunal y a un sistema de rinovacunación para prevenir y tratar la hepatitis B como se muestra en la figura 1.</p>
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018107797 | 2018-06-05 | ||
| PCT/JP2019/022136 WO2019235466A1 (ja) | 2018-06-05 | 2019-06-04 | Ｂ型肝炎ワクチン経鼻投与システム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CU20200097A7 true CU20200097A7 (es) | 2021-07-02 |
| CU24686B1 CU24686B1 (es) | 2023-11-07 |
Family
ID=68769323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU2020000097A CU24686B1 (es) | 2018-06-05 | 2019-06-04 | Composición de vacuna contra la hepatitis b, proceso de obtención de dicha composición y sistema de rinovacunación para prevenir y tratar la hepatitis b |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US12070497B2 (es) |
| EP (1) | EP3804752A4 (es) |
| JP (1) | JP7685834B2 (es) |
| KR (1) | KR102905178B1 (es) |
| CN (1) | CN112368018A (es) |
| AU (1) | AU2019283122B2 (es) |
| BR (1) | BR112020022784A2 (es) |
| CA (1) | CA3099430A1 (es) |
| CU (1) | CU24686B1 (es) |
| IL (1) | IL278415B2 (es) |
| MX (1) | MX2020013240A (es) |
| MY (1) | MY206419A (es) |
| PH (1) | PH12020552075A1 (es) |
| SG (1) | SG11202011004RA (es) |
| TW (1) | TWI887202B (es) |
| WO (1) | WO2019235466A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116077816B (zh) * | 2023-04-11 | 2023-06-16 | 无锡耐思生命科技股份有限公司 | 一种雾化喷头和喷雾装置 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030180351A1 (en) | 1998-11-06 | 2003-09-25 | Reinhard Gluck | Pharmaceutically active composition and dispensing device |
| DE19851282A1 (de) | 1998-11-06 | 2000-05-11 | Schweiz Serum & Impfinst | Zusammensetzung einer pharmazeutisch wirksamen Substanz, appliziert in einem spezifischen Delivery-System zur Prävention und Behandlung von Infektions-Krankheiten |
| CU22871A1 (es) | 1998-12-02 | 2003-10-21 | Ct Ingenieria Genetica Biotech | Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal |
| JP2004527524A (ja) | 2001-04-05 | 2004-09-09 | カイロン コーポレイション | 非経口初回抗原刺激後の粘膜追加免疫 |
| US20090306341A1 (en) | 2005-07-29 | 2009-12-10 | Joachim Emmert | LC/MS Blends Containing Ionizing Additives |
| JP5185109B2 (ja) | 2006-04-21 | 2013-04-17 | 東興薬品工業株式会社 | スプレー用ゲルタイプ皮膚・粘膜付着型製剤およびそれを用いた投与システム |
| AU2010232180B2 (en) | 2009-03-31 | 2016-09-22 | Japan As Represented By The Director-General Of National Institute Of Infectious Diseases | Method for prophylaxis of influenza using vaccine for intranasal administration |
| WO2013145789A1 (ja) | 2012-03-30 | 2013-10-03 | 株式会社吉野工業所 | 定量シリンジ型噴出器 |
| DK3162378T3 (da) * | 2014-06-25 | 2024-03-18 | Toko Yakuhin Kogyo Kk | Nasalvaccinationssystem til influenzavaccine |
| JP6322844B2 (ja) | 2014-06-25 | 2018-05-16 | 東興薬品工業株式会社 | 医療用シリンジに用いられる点鼻用噴霧ノズル |
| RU2603729C2 (ru) | 2015-04-24 | 2016-11-27 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | Рекомбинантная вакцина для профилактики вирусного гепатита в (варианты) |
| JP6558392B2 (ja) * | 2017-04-04 | 2019-08-14 | ニプロ株式会社 | シリンジ型噴出装置 |
-
2019
- 2019-06-04 MX MX2020013240A patent/MX2020013240A/es unknown
- 2019-06-04 JP JP2020523114A patent/JP7685834B2/ja active Active
- 2019-06-04 BR BR112020022784-6A patent/BR112020022784A2/pt unknown
- 2019-06-04 WO PCT/JP2019/022136 patent/WO2019235466A1/ja not_active Ceased
- 2019-06-04 CA CA3099430A patent/CA3099430A1/en active Pending
- 2019-06-04 US US15/734,148 patent/US12070497B2/en active Active
- 2019-06-04 CN CN201980035576.2A patent/CN112368018A/zh active Pending
- 2019-06-04 TW TW108119325A patent/TWI887202B/zh active
- 2019-06-04 AU AU2019283122A patent/AU2019283122B2/en active Active
- 2019-06-04 IL IL278415A patent/IL278415B2/en unknown
- 2019-06-04 CU CU2020000097A patent/CU24686B1/es unknown
- 2019-06-04 KR KR1020207038093A patent/KR102905178B1/ko active Active
- 2019-06-04 SG SG11202011004RA patent/SG11202011004RA/en unknown
- 2019-06-04 EP EP19816086.3A patent/EP3804752A4/en active Pending
- 2019-06-04 MY MYPI2020005758A patent/MY206419A/en unknown
-
2020
- 2020-12-03 PH PH12020552075A patent/PH12020552075A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102905178B1 (ko) | 2025-12-26 |
| TW202002950A (zh) | 2020-01-16 |
| JP7685834B2 (ja) | 2025-05-30 |
| PH12020552075A1 (en) | 2021-05-31 |
| TWI887202B (zh) | 2025-06-21 |
| JPWO2019235466A1 (ja) | 2021-06-24 |
| IL278415B1 (en) | 2023-06-01 |
| CU24686B1 (es) | 2023-11-07 |
| EP3804752A1 (en) | 2021-04-14 |
| MY206419A (en) | 2024-12-17 |
| KR20210022009A (ko) | 2021-03-02 |
| US20210187101A1 (en) | 2021-06-24 |
| WO2019235466A1 (ja) | 2019-12-12 |
| CN112368018A (zh) | 2021-02-12 |
| MX2020013240A (es) | 2021-05-12 |
| CA3099430A1 (en) | 2019-12-12 |
| BR112020022784A2 (pt) | 2021-02-02 |
| SG11202011004RA (en) | 2020-12-30 |
| AU2019283122B2 (en) | 2026-02-05 |
| IL278415A (es) | 2020-12-31 |
| AU2019283122A1 (en) | 2020-11-26 |
| EP3804752A4 (en) | 2022-03-09 |
| US12070497B2 (en) | 2024-08-27 |
| IL278415B2 (en) | 2023-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR102657A1 (es) | Composición para tratar telas | |
| MX2021006681A (es) | Anticuerpos anti-claudina y usos de los mismos. | |
| AR100215A1 (es) | Conjugados de anticuerpo-fármaco anti-ptk7 | |
| JOP20170130A1 (ar) | مركبات لمعالجة عدوى فيروس التهاب الكبد الوبائي b | |
| JOP20180008A1 (ar) | مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b | |
| PE20180601A1 (es) | Formulaciones para vacunas contra la neoplasia y metodos para preparar las mismas | |
| MX2022005372A (es) | Combinaciones y formulaciones de dosis fijas que comprenden etc-1002 y una o mas estatinas. | |
| MX2019012452A (es) | Meganucleasas diseñadas especificas para secuencias de reconocimiento en el gen pcsk9. | |
| ZA202403393B (en) | Synthetic chimeric poxviruses | |
| BR112017004393A2 (pt) | formulações de anticorpo | |
| PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
| CU24580B1 (es) | Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas | |
| MX378904B (es) | Vacunas para virus influenza y usos de las mismas. | |
| EA201990010A1 (ru) | Вакцина против вируса инфекционного бронхита | |
| MX2022006817A (es) | Formulaciones/composiciones que comprenden un inhibidor de btk. | |
| BR112019024566A2 (pt) | inibidores de pirazol magl | |
| MX2020004633A (es) | Metodo para inactivar el virus de zika y metodos relacionados. | |
| MX381211B (es) | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. | |
| CL2021002807A1 (es) | Anticuerpos y métodos para el tratamiento de la infección por influenza a | |
| BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
| MX2022013775A (es) | Material generador de aerosol. | |
| MX2017000154A (es) | Sistema de rinovacunacion de la vacuna contra la influenza. | |
| CY1125031T1 (el) | Μεθοδος για γενετικη θεραπεια χρησιμοποιωντας τον ιο aav-xbp1s/gfp και χρηση αυτης στην προληψη και τη θεραπεια της αμυοτροφικης πλευρικης σκληρυνσης | |
| WO2020012428A8 (en) | New vaccines against avian reoviruses | |
| EA201892003A1 (ru) | Лечение атопического дерматита собак |